XML 15 R9.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash Flows from Operating Activities              
Net Income (Loss) $ 5,270 $ (6,974) $ 3,185 $ 2,548 $ (1,704) $ 5,733  
Adjustments to reconcile net income to net cash provided by operating activities:              
Depreciation         389 498  
Amortization of other assets         543 182  
Origination of loans held for sale         (42,521) (29,466)  
Proceeds from sale of loans held for sale         43,418 28,722  
Net (gain) on sales of loans         (1,528) (653)  
Provision for credit losses on loans 856   314   2,002 789 $ 2,525
(Gain) on the sale of portfolio loans         (5) 0  
Loss on the sale and disposal of premises and equipment 0   11   16 11  
Loss on the sale of repossessed assets 0   0   133 0  
Loss on the sale of securities 0   0   12,425 0  
Amortization of subordinated debt issuance costs         33 34  
Stock-based compensation expense         613 551  
(Accretion) amortization of premiums and discounts on debt securities and loans, net         (273) 138  
Bank-owned life insurance income         (551) (537)  
(Gain) on bank-owned life insurance settlement         0 (254)  
Changes in assets and liabilities:              
(Increase) in other assets         (539) (967)  
(Decrease) increase in other liabilities         (4,085) 152  
Net cash provided by operating activities         8,366 4,933  
Cash Flows from Investing Activities              
Proceeds from maturities, calls, and principal payments of securities available for sale         6,899 6,863  
Proceeds from the sale of securities available for sale         86,822 0  
Purchases of securities available for sale         (91,155) 0  
Proceeds from the sale of restricted investments         3,815 1,425  
Purchases of restricted investments         (44) (637)  
Proceeds of bank-owned life insurance settlement         0 263  
Purchases of bank premises and equipment         (799) (515)  
Proceeds from the sale of bank premises and equipment         40 0  
Proceeds from the sale of repossessed assets         381 12 111
Proceeds from the sale of portfolio loans         18,772 0  
Net decrease in loans         8,290 13,372  
Funding of capital commitments related to other investments         (492) (664)  
Net cash provided by investing activities         32,529 20,119  
Cash Flows from Financing Activities              
Net increase (decrease) in noninterest bearing demand deposits, savings, and interest bearing demand deposits         217,456 (30,683)  
Net (decrease) increase in time deposits         (26,088) 12,945  
Net increase in federal funds purchased         172 302  
Repayments of short-term Federal Home Loan Bank advances         (25,000) (20,000)  
Repayments of long-term Federal Home Loan Bank advances         (55,000) 0  
Net proceeds from issuance of common stock in public offering         53,501 0  
Repurchase and retirement of common stock         (315) (180)  
Cash dividends paid         (2,778) (2,134)  
Net cash provided (used) by financing activities         161,948 (39,750)  
Increase (decrease) in cash and cash equivalents         202,843 (14,698)  
Cash and Cash Equivalents              
Beginning   $ 193,159   $ 138,353 193,159 138,353 138,353
Ending $ 396,002   $ 123,655   396,002 123,655 $ 193,159
Supplemental Disclosures of Cash Flow Information              
Interest         20,125 19,037  
Income taxes         1,200 0  
Supplemental Schedule of Noncash Investing and Financing Activities:              
Unrealized gain (loss) on securities available for sale         14,358 (953)  
Minimum postretirement liability adjustment         0 (5)  
Repossessed assets acquired in settlement of loans         186 111  
Lease liabilities arising from right-of-use assets         $ 773 $ 0